Sagtec Global Receives Nasdaq Minimum Bid Price Deficiency Notice
SAGT is trading near its 52-week low of $0.62 (5.8% above the low).
Summary
Sagtec Global received a Nasdaq notice on August 18, 2026 for failing to maintain a $1.00 minimum bid price. The company has 180 days to regain compliance and may pursue a reverse stock split.
Key Events · Legal and Risk Events · SAGT
-
Nasdaq Deficiency Notice Received
On August 18, 2026, Sagtec received a Nasdaq Listing Qualifications Staff Determination Letter stating its Class A Ordinary Shares closed below $1.00 for 30 consecutive business days, violating Listing Rule 5550(a)(2).
-
Compliance Deadline Set
The company has 180 calendar days, until February 16, 2027, to regain compliance by achieving a closing bid price of at least $1.00 for 10 consecutive business days.
-
Reverse Stock Split Considered
If compliance is not regained by the deadline, Sagtec may be eligible for a second 180-day period and may implement a reverse stock split to cure the deficiency, which must be completed no later than 10 business days before the compliance period expires.
-
Delisting Risk
If Nasdaq determines the company cannot cure the deficiency or is ineligible for an extension, the Class A Ordinary Shares will be subject to delisting, subject to appeal.
Analysis · SAGT · Technology
Sagtec Global's Class A Ordinary Shares have traded below $1.00 for 30 consecutive business days, triggering a Nasdaq deficiency notice. The company has until February 16, 2027 to regain compliance, with a possible second 180-day extension if it meets other listing standards. A reverse stock split is explicitly mentioned as a potential remedy. This is a critical listing risk event that could lead to delisting if not cured, and it comes despite strong recent operational news including a $3M AI robot order and insider buying.
At the time of this filing, SAGT was trading at $0.66 on NASDAQ in the Technology sector, with a market capitalization of approximately $15.6M. The 52-week trading range was $0.62 to $3.39. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.